/Investor DB

20/20 HealthCare Partners LLC

Venture capital

Auburndale · Seed–Series A · 7 people tracked

Find your way into 20/20 HealthCare Partners LLC

Sign up to see every warm intro you have to 20/20 HealthCare Partners LLC

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the 20/20 HealthCare Partners LLC team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

✨ Fox Verdict
Sign up to see your fit

Investment thesis

20/20 HCP invests at the early stage of life sciences and healthcare technology, targeting companies in diagnostic imaging, medical devices, healthcare IT, biotechnology and pharmaceuticals. It focuses on the phase after proof of concept has been established, funding program development through to the completion of verification and validation studies (pre-regulatory approval and pre-commercialization). It typically acts as lead investor providing managerial and operational support alongside capital, aiming for short investment periods of about 2-3 years to exit and returns in the 3-7x range, with exit routes including sale, licensing, partnership with big pharma, or a follow-on financing round.

Source: firm website, verified Aug 3, 2026.

Stage
Seed–Series A
HQ
Auburndale, Massachusetts, US
Leads rounds
Leads
Instruments
Equity
Founded
2005
Tracked investments
17
Acquisitions
2

Team · 7 people

from the firm's website & public directories
Len Singer· Financial & Structuring Director
Ronny Vinasco Bachrach· Marketing Director
Vito Levi D’Ancona· Advisory Board

What they invest in

from 10 of 17 portfolio companies

Healthtech ×9Biotech ×5Medical Devices ×4AI & Machine Learning ×3Digital Health ×2Cloud Computing ×1Deep Tech ×1Enterprise Software ×1

HQs:United States×7

Investments · 17 tracked

founders shown can be your intro path

By year:2024 · 12021 · 12017 · 13 dated

Variantyxvariantyx.cominFeb 2021✓ verified

Variantyx is a molecular diagnostics company offering genetic testing for rare genetic disorders, reproductive genetics, and precision oncology.

AI & Machine LearningBiotechDigital HealthHealthtechFramingham, US

Haim Neerman(Co-founder)inTomer Jackman(Co-founder & VP Customer Support and Lab Services)inJeffrey Weisberg(Chief Financial Officer)inYaron Rachmany(Operations, R&D, IT (executive))inChristine Stanley(Chief Genomics and Compliance Officer)inEyal Reinstein(Chief Medical Officer)in

Co-investorsBosch VenturesNew Era Capital PartnersOrbiMedPeregrine VenturesPitangoQuark Venture Inc.+2 more

Coagulo Medical Technologies, Inc.coagulomed.comin

Coagulo develops a portable point-of-care testing platform for coagulation disorder diagnosis and management using microfluidic technology and data analytics.

BiotechDeep TechHealthtechMedical Devices

PartnerHillel Bachrach· solo GP

Co-investorsGood Growth CapitalNew World AngelsService Provider Capital

EnClear Therapiesencleartherapies.cominFeb 2024

EnClear Therapies is a bio/med-tech company developing the EnTrega CSF platform, focused on cerebrospinal fluid-related therapies.

BiotechDigital HealthHealthtechMedical DevicesCambridge, US

Anthony DePasqua(Executive Officer, Director)inKevin Kalish(COO)inMarcie Glicksman(VP Biology)inWilliam Gormley(CMO)Jason Camm(Director)Kasper Roet(Director)in

PartnerHillel Bachrach· led

Co-investorsDolby Family VenturesFlucas VenturesTachyon VenturesVU Venture PartnersAmgen VenturesBioverge+1 more

Remedy Planremedyplan.comin

Remedy Plan is a biopharmaceutical company developing drugs that target NAMPT, an essential enzyme dysregulated in more than 20 diseases including cancer.

BiotechHealthtechRockville, US

Gregory Plan Crimmins(Executive Officer, Director)

PartnerHillel Bachrach· solo GP

Co-investorsSchooner CapitalAlexandria

Ultraspectultraspect.com

UltraSPECT develops image reconstruction technology that enables lower-dose and faster nuclear cardiology, oncology, and bone imaging exams.

AI & Machine LearningHealthtechMedical Devices

PartnerHillel Bachrach· solo GP

Verseau Therapeuticsverseautx.cominMar 2017

Verseau Therapeutics discovers and develops macrophage-targeting monoclonal antibodies to enhance anti-tumor immune responses in cancer patients.

AI & Machine LearningBiotechHealthtechMedical DevicesAuburndale, US

Bob Langer(Director, Promoter)Dan Anderson(Executive Officer, Director, Promoter)inTatiana NovobrantsevainIgor FeldmaninWalter Capone(Executive Officer)Christine Bunt(Executive Officer, Director)in

PartnerHillel Bachrach· led

Co-investorsHighlight CapitalYonghua Capital

XRHealthin

XR therapeutics platform company that merged with Amelia Virtual Care.

HealthtechNeedham, US

Eran Orr(Founder & Chief Executive Officer)in

PartnerHillel Bachrach· solo GP

Co-investorsAI CapitalAsabys PartnersBridges IsraelFlying Tiger CapitalKeyhorse CapitalCriteria Venture Tech+2 more

Zixizixi.comin𝕏acquired by Clearhaven Partners

Zixi provides software solutions for broadcast and live video workflows, serving content owners, broadcasters, service providers, sports organizations, and OTT providers with capabilities for content contribution, satellite replacement, B2B distribution, and direct-to-consumer enablement.

Cloud ComputingEnterprise SoftwareMedia & EntertainmentSaaS

Uri Avni(Co-Founder, CTO)

PartnerHillel Bachrach· led

Co-investorsSchooner Capital

Other

Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.

Corindus Vascular RoboticsEnclearHighRadNEMDXPhysIQQBiotixSQZ BiotechnologyVelocompViztek

Exits · 2

2 acquisitions

Viztekacq. by Konica MinoltaZixiacq. by Clearhaven Partners

Portfolio news

latest coverage across their companies

Frequently asked questions

How many investments has 20/20 HealthCare Partners LLC made?
20/20 HealthCare Partners LLC has 17 tracked investments, 2 of which have exited.
What stage does 20/20 HealthCare Partners LLC invest at?
20/20 HealthCare Partners LLC invests at the Seed, Series A stages.
What sectors does 20/20 HealthCare Partners LLC focus on?
20/20 HealthCare Partners LLC focuses on AI & Machine Learning, Biotech, Digital Health, Healthtech, Media & Entertainment, Medical Devices.
Where is 20/20 HealthCare Partners LLC located?
20/20 HealthCare Partners LLC is headquartered in Auburndale, US.
Does 20/20 HealthCare Partners LLC lead rounds?
Yes, 20/20 HealthCare Partners LLC leads investment rounds.
Who does 20/20 HealthCare Partners LLC co-invest with?
20/20 HealthCare Partners LLC most often shares deals with Flying Tiger Capital, Schooner Capital, AI Capital, among 17 tracked co-investors.

Images

20/20 HealthCare Partners LLC photo20/20 HealthCare Partners LLC photo20/20 HealthCare Partners LLC photo

Similar investors

Featured in lists